![Jenburkt, second in India to launch Favipiravir (Favivent™) to fight COVID-19](https://jenburkt.com/website/wp-content/uploads/2017/02/Favivent_Product-Packshot-670x446.jpg)
Jenburkt, second in India to launch Favipiravir (Favivent™) to fight COVID-19
Mumbai, India; 24th July, 2020: India has recently crossed the 1.28 million* mark of COVID-19 cases and has turned into a global hotspot of coronavirus. In an important development for COVID-19 patients in India, Jenburkt Pharmaceuticals Ltd., a public…
Read more